-+ 0.00%
-+ 0.00%
-+ 0.00%

Kehua Biotech (002022.SZ) subsidiary obtained multiple medical device registration certificates

Zhitongcaijing·12/15/2025 11:41:07
Listen to the news

Zhitong Finance App News, Kehua Biotech (002022.SZ) announced that the company's holding subsidiary Xi'an Tianlong Technology Co., Ltd. (“Xi'an Tianlong”) and its wholly-owned subsidiary Kehua (Xi'an) Biotechnology Co., Ltd. (“Xi'an Kehua”) have each received medical device registration certificates (in vitro diagnostic reagents) issued by the China Drug Administration and the Shaanxi Drug Administration. The product names are: human CYP3A5 gene polymorphism test kit (fluorescence PCR), 25-hydroxyvitamin D test kit (liquid chromatography-tandem mass spectrometry), cyclosporine, tacrolimus, and rapamycin detection kit (liquid phase spectrometry-tandem mass spectrometry).